Difficulty: Medium
Average Score: 73%
Practice
Which of the following sympathomimetics is preferable for the emergency therapy of cardiogenic shock?
Correct answer
B
Rationale
In the context of pharmacology and lifespan considerations, understanding the appropriate sympathomimetic agent for the emergency therapy of cardiogenic shock is crucial. In this scenario, the correct answer is B) Dobutamine.
Dobutamine is preferable for cardiogenic shock because it is a beta-1 adrenergic agonist that primarily acts on the heart to increase cardiac contractility. This effect helps improve cardiac output and perfusion to vital organs, which is essential in the management of cardiogenic shock where the heart's ability to pump effectively is compromised.
Now, let's discuss why the other options are incorrect:
A) Epinephrine: While epinephrine is a potent sympathomimetic agent, its non-selective action on alpha and beta receptors can lead to increased afterload and potential vasoconstriction, which may worsen the condition in cardiogenic shock.
C) Isoproterenol: Isoproterenol primarily stimulates beta receptors and can lead to tachycardia and increased myocardial oxygen demand, which can be detrimental in cardiogenic shock.
D) Methoxamine: Methoxamine is an alpha-1 adrenergic agonist that primarily causes vasoconstriction without directly improving cardiac contractility, making it less suitable for the management of cardiogenic shock.
Educationally, this question highlights the importance of selecting the appropriate sympathomimetic agent based on its mechanism of action and the specific pathophysiology of the condition being treated. Understanding the pharmacological properties of each drug in relation to the clinical scenario is essential for making informed decisions in emergency situations like cardiogenic shock.
Dobutamine is preferable for cardiogenic shock because it is a beta-1 adrenergic agonist that primarily acts on the heart to increase cardiac contractility. This effect helps improve cardiac output and perfusion to vital organs, which is essential in the management of cardiogenic shock where the heart's ability to pump effectively is compromised.
Now, let's discuss why the other options are incorrect:
A) Epinephrine: While epinephrine is a potent sympathomimetic agent, its non-selective action on alpha and beta receptors can lead to increased afterload and potential vasoconstriction, which may worsen the condition in cardiogenic shock.
C) Isoproterenol: Isoproterenol primarily stimulates beta receptors and can lead to tachycardia and increased myocardial oxygen demand, which can be detrimental in cardiogenic shock.
D) Methoxamine: Methoxamine is an alpha-1 adrenergic agonist that primarily causes vasoconstriction without directly improving cardiac contractility, making it less suitable for the management of cardiogenic shock.
Educationally, this question highlights the importance of selecting the appropriate sympathomimetic agent based on its mechanism of action and the specific pathophysiology of the condition being treated. Understanding the pharmacological properties of each drug in relation to the clinical scenario is essential for making informed decisions in emergency situations like cardiogenic shock.